The largest database of trusted experimental protocols

Dithiothreitol (dtt)

Manufactured by Thermo Fisher Scientific
Sourced in United States, United Kingdom, Germany, Belgium, France, Switzerland, Canada, China, Sweden, Japan, Morocco, Hungary, Netherlands

DTT (Dithiothreitol) is a reducing agent commonly used in biochemistry and molecular biology applications. It is a small, water-soluble molecule that helps maintain the reduced state of cysteine residues in proteins. DTT is often used in protein purification, gel electrophoresis, and other procedures where the preservation of protein structure and function is essential.

Automatically generated - may contain errors

766 protocols using dithiothreitol (dtt)

1

Tau Aggregation Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human P301L tau was dialyzed into 100 mM sodium acetate buffer pH 7.4 overnight. Samples consisting of 20 μM P301L tau and 2x the indicated concentration of compound were incubated at room temperature for 1 hour prior to starting the assay. Using a master mix of 2x concentrated heparin (MP Biomedicals, Santa Anna, CA), Thioflavin T (Sigma-Aldrich, St. Louis, MO), and dithiothreitol (ThermoFisher Scientific, Waltham, MA), samples were diluted to a final concentration of 10 μM P301L tau, 2.5 μM heparin, 10 μM Thioflavin T, the compounds at indicated concentrations or DMSO, and 2 mM dithiothreitol in 100 mM sodium acetate at pH 7.4. A total of 200 μL was added to each well of a low binding 96-well black sided clear bottom costar plate (Corning, Corning, NY). Each plate was incubated at 37 °C, and fluorescence intensity (440 excitation, 482 emission) was measured over a 5-day period using a BioTek (Winooski, VT) Synergy H1 microplate reader.
+ Open protocol
+ Expand
2

Tau Aggregation Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human P301L tau was dialyzed into 100 mM sodium acetate buffer pH 7.4 overnight. Samples consisting of 20 μM P301L tau and 2x the indicated concentration of compound were incubated at room temperature for 1 hour prior to starting the assay. Using a master mix of 2x concentrated heparin (MP Biomedicals, Santa Anna, CA), Thioflavin T (Sigma-Aldrich, St. Louis, MO), and dithiothreitol (ThermoFisher Scientific, Waltham, MA), samples were diluted to a final concentration of 10 μM P301L tau, 2.5 μM heparin, 10 μM Thioflavin T, the compounds at indicated concentrations or DMSO, and 2 mM dithiothreitol in 100 mM sodium acetate at pH 7.4. A total of 200 μL was added to each well of a low binding 96-well black sided clear bottom costar plate (Corning, Corning, NY). Each plate was incubated at 37 °C, and fluorescence intensity (440 excitation, 482 emission) was measured over a 5-day period using a BioTek (Winooski, VT) Synergy H1 microplate reader.
+ Open protocol
+ Expand
3

SDS-PAGE Protein Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For SDS-PAGE analysis, precast 4–20% Bis-Tris gradient gels (Genscript, Picastaway, USA) in a Tris-MOPS running buffer was used. The molecular weight marker was Pierce™ Unstained MW marker (Thermo Scientific). Maximum volume of 20 µL was loaded in the wells on the SDS-PAGE gel. Solubilized extracts were mixed 14:5:1 with a 4xSDS sample buffer (50 mM Tris (VWR, Leuven, Belgium) pH 6.8, 2% SDS, 10% glycerol (VWR), 0.02% bromophenol blue (Sigma-Aldrich), 12.4 mM ethylenediaminetetraAcetic acid (EDTA, Carl Roth, Karlsruhe, Germany)) and 1 M dithiothreitol (DTT, Thermo Scientific), corresponding to a final DTT concentration of 50 mM. The samples incubated at 95 °C for 5 min to denature proteins. Running time for the gel was 45 min at 140 V. To visualize proteins, the gel was stained with Coomassie Brilliant Blue G250 (29 mM Coomassie Brilliant Blue G-250 (Sigma-Aldrich), 45% Ethanol (VWR), 10% Acetic acid (Fisher Scientific, Loughborough, UK)). Destaining of the gel was performed overnight with destain solution (8% Ethanol, 5% Acetic acid). Imaging of the gel was done using a ChemDoc MP Imaging System (Bio-Rad, Hercules, USA).
+ Open protocol
+ Expand
4

Infection Assay for Airway Epithelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human nasal epithelial cells (PromoCell) were pretreated with compounds for 3 hours, infected with virus at MOI=3 and incubated with medium containing 2 μM inhibitors for 48 hours, and fixed with 4% paraformaldehyde in PBS.
Primary human bronchial epithelial cells were cultured on 6.5-mm transwell inserts (Corning, Corning, NY, USA) for 4 weeks at air-liquid interface to obtain a well-differentiated epithelium. Mucus was removed immediately prior to viral infection by washing the apical surface with a prewarmed solution of 10 mM dithiothreitol (DTT; Thermo) in PBS for 10 minutes and then washed twice with PBS without DTT. Cells were inoculated by adding virus to the apical surface at MOI=1. After 1 h, the apical surface was washed twice with PBS and cells were returned to the incubator. Cells were fixed at 72 h post-infection in 4% paraformaldehyde in PBS.
+ Open protocol
+ Expand
5

Oligonucleotide Reduction and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oligonucleotide stock solution was added to dithiothreitol (DTT) (Acros Organics, Thermo Fisher Scientific, NJ, USA) in 20 mM sodium phosphate buffer at pH 7.4, bringing [DTT]final to 100 mM, and [oligo]final to 10 μM. The reduction reaction was allowed to proceed at room temperature protected from light for 60 minutes. DTT was removed by buffer exchange using a 15 mL, 3 kD molecular weight cutoff spin concentrator according to manufacturer’s instructions (EMD Millipore, Billerica, MA). In brief, the reaction solution was added to the reservoir of the spin concentrator and brought to 15 mL with 20 mM pH 7.4 sodium phosphate buffer. The concentrator was spun at 4000 × g for 30 minutes until approximately 500 μL was concentrated in the reservoir. The flow-through was then discarded, and the reservoir volume was brought back up to 15 mL with fresh 20 mM sodium phosphate buffer. The concentrator was spun for a total of four buffer exchange cycles. The resulting 500 μL concentrate was collected for analysis by mass spectrometry before proceeding with the next step of the synthesis.
+ Open protocol
+ Expand
6

Purification of p300-CH1-GST Fusion Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 3

The pGEX-4T-2-p300 fusion vector was transformed into BL21(DE3) competent E.coli (Novagen) in M9 minimal media with 15NH4Cl as the primary nitrogen source. Protein production was induced with 1 mM IPTG at OD600 of 1 for 16 hours at 15° C. Production of the desired p300-CH1-GST fusion product was verified by SDS-PAGE. Bacteria were harvested and resuspended in the lysis buffer with 20 mM Phosphate buffer (Research Products International, Corp.), 100 μM DTT (Fisher), 100 μM ZnSO4 (Sigma), 0.5% TritonX 100 (Sigma), 1 mg/mL Pepstatin A (Research Products International, Corp.), 10 mg/mL Leupeptin A (Research Products International, Corp.), 500 μM PMSF (Sigma), and 0.5% glycerol at pH 8.0. Pellets were lysed by sonication and centrifuged at 4° C. and 20,000 rpm for 20 minutes. Fusion protein was collected from the bacterial supernatant and purified by affinity chromatography using glutathione Sepharose 4B beads (Amersham) prepared according to the manufacturer's directions. GST-tag was cleaved by thrombin and protein was eluted from resin. Collected fractions were assayed by SDS-PAGE gel; pooled fractions were treated with protease inhibitor cocktail (Sigma) and against a buffer containing 10 mM Tris, 50 mM NaCl, 2 mM DTT (Fisher), and 3 equivalents ZnSO4 at pH 8.0 to ensure proper folding (vide supra).

+ Open protocol
+ Expand
7

Purification of p300-CH1-GST Fusion Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 3

The pGEX-4T-2-p300 fusion vector was transformed into BL21(DE3) competent E. coli (Novagen) in M9 minimal media with 15NH4Cl as the primary nitrogen source. Protein production was induced with 1 mM IPTG at OD600 of 1 for 16 hours at 15° C. Production of the desired p300-CH1-GST fusion product was verified by SDS-PAGE. Bacteria were harvested and resuspended in the lysis buffer with 20 mM Phosphate buffer (Research Products International, Corp.), 100 μM DTT (Fisher), 100 μM ZnSO4 (Sigma), 0.5% TritonX 100 (Sigma), 1 mg/mL Pepstatin A (Research Products International, Corp.), 10 mg/mL Leupeptin A (Research Products International, Corp.), 500 μM PMSF (Sigma), and 0.5% glycerol at pH 8.0. Pellets were lysed by sonication and centrifuged at 4° C. and 20,000 rpm for 20 minutes. Fusion protein was collected from the bacterial supernatant and purified by affinity chromatography using glutathione Sepharose 4B beads (Amersham) prepared according to the manufacturer's directions. GST-tag was cleaved by thrombin and protein was eluted from resin. Collected fractions were assayed by SDS-PAGE gel; pooled fractions were treated with protease inhibitor cocktail (Sigma) and against a buffer containing 10 mM Tris, 50 mM NaCl, 2 mM DTT (Fisher), and 3 equivalents ZnSO4 at pH 8.0 to ensure proper folding (vide supra).

+ Open protocol
+ Expand
8

SARS-CoV-2 Infection of Human Airway Epithelia

Check if the same lab product or an alternative is used in the 5 most similar protocols
SARS-CoV-2 virus (USA-WA1/2020 strain) was provided by Dr. Melanie Ott and propagated in Vero E6 cells. HBECs were cultured in the absence or presence of IL-13 (10 ng/ml). Mucus was allowed to accumulate for 3 days or was removed immediately before viral infection by washing the apical surface with a prewarmed solution of 10 mM DTT (Thermo) in PBS for 10 minutes (26 (link)) and then washing twice with PBS without DTT. Cells were inoculated by adding virus to the apical surface. After 2 hours, the apical surface was washed twice with PBS, and cells were returned to the incubator. Cells were harvested 48 hours after infection for analysis of viral RNA (by qRT-PCR) and double-stranded RNA (dsRNA) staining (by immunofluorescence).
+ Open protocol
+ Expand
9

Protein Expression Analysis of Explanted mSVF

Check if the same lab product or an alternative is used in the 5 most similar protocols
Explanted mSVF was homogenized by sonication and lysates were acquired by lithium dodecyl sulfate (LDS)/ dithiothreitol (DTT) buffer LDS/DTT buffer (25% (v/v) NuPAGE lithium LDS sample buffer (Invitrogen, Karlsruhe, Germany), 50 mM DTT (Sigma-Aldrich, Munich, Germany), bidistilled water (ddH2O)). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) for Akt (55 kDa), pAkt (56–60 kDa), ERK/pERK-1/2 (42–44 kDa), actin (43 kDa) and α-tubulin were performed on 10% polyacrylamide gels. For Western blotting, the primary antibodies Akt (Abcam, Cambridge, UK), pAkt (Abcam, Cambridge, UK), ERK1/2 (Cell Signaling Technology, Danvers, MA, USA), pERK1/2 (Cell Signaling Technology, Danvers, MA, USA), actin (Merck& Co., Kenilworth, NJ, USA), α tubulin (Abcam, Cambridge, UK) and the secondary antibodies HRP-goat anti-mouse IgG, HRP-goat anti-rabbit IgG and HRP-rabbit anti-rat IgG from Abcam, Cambridge, UK were used. HRP on the blots was detected by ECL substrate (Bio-Rad Laboratories, Hercules, CA, USA).
+ Open protocol
+ Expand
10

Isolation of Intestinal Epithelial and Lamina Propria Lymphocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Steady-state intestinal epithelial and lamina propria lymphocytes were harvested as previously described49 (link). To isolate IECs, intestinal tissues were first incubated in 5 mM EDTA (Invitrogen) in HBSS (Gibco) containing 1 mM DTT (Invitrogen) for 20 minutes at 37°C with 200rpm agitation, and then incubated in a second wash of 5 mM EDTA in HBSS without DTT for another 20 minutes at 37°C with agitation. Single-cell suspensions released into the EDTA solutions were pooled and confirmed to contain over 85% EpCAM+ IECs as reported previously39 (link). For the lamina propria, IEC-depleted tissues from post-EDTA washes were digested in a HBSS solution containing 10% Fetal Bovine Serum (Peak Serum), 1.0 mg/ml Collagenase D (Roche), 100 μg/ml DNase I (Sigma-Aldrich), and 50 U/ml dispase (Worthington Biochemical Corporation) at 37°C for 30–45 minutes. Lamina propria mononuclear lymphocytes were purified from the interphase of a 40:80% Percoll (Cytiva; formerly GE Healthcare Life Sciences) gradient.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!